Zurueck zur Suche

Reporte zur Charge U7178AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 1 VA 1

VAERS 2531821

SANOFI PASTEUR · HIB (ACTHIB) · Charge U7178AA

gering
Staat
IL
Alter
1,3
Geschlecht
M
Eingang
15.12.2022
Impfdatum
09.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event Product preparation error

Symptomtext

Medical assistant administered ACTHIB to 15-month-old patient and the diluent was expired with no reported adverse event; Medical assistant administered ACTHIB to 15-month-old patient and the diluent was expired with no reported adverse event; Initial information received on 12-Dec-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 months old male patient and it was reported medical assistant administered acthib to 15-month-old patient and the diluent was expired with no reported adverse event after receiving HIB (PRP/T) vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s), concomitants and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Daptacel) for immunisation; influenza vaccine inact split 4V (Fluzone quadrivalent) for immunisation; and diphtheria vaccine toxoid, HIB vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3V (MRC 5), tetanus vaccine toxoid (Pentacel) for immunisation. On 09-Dec-2022, the patient received 0.5 ml of suspect HIB (PRP/T) vaccine powder and solvent for solution for injection (lot number- U7178AA and expiry date- 30-Nov-2022; strength, formulation: unknown) via unknown route in unknown administration site for immunization. On an unknown date, it was reported that medical assistant administered ACTHIB to 15-month-old patient and the diluent was expired with no reported adverse event (expired medical agent used) (vaccine preparation error) (latency: unknown) following the administration of HIB (PRP/T) vaccine. Action taken: Not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2256500

SANOFI PASTEUR · HIB (ACTHIB) · Charge U7178AA

gering
Staat
VA
Alter
0,8
Geschlecht
F
Eingang
28.04.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

patient was administered two doses of ACTHIB on 21APR2022 with no reported adverse event; Initial information received on 21-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 months old female patient who was administered two doses of hib (prp/t) vaccine (Act-Hib) on 21apr2022 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 7v (crm197) (Prevnar); diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Dtap); and Rotavirus Vaccine. On 21-Apr-2022, the patient received 0.5ml doses totaling 1.0 ml of suspect hib (prp/t) vaccine lot U7178AA and expiry date: 30-Nov-2022 (strength, frequency was unknown) via intramuscular route in the left thigh and right thigh for Immunization.Lyophilized powder vial (Lot:UJ614AB Expiration date: 12-Mar-2023) Diluent (Lot: U7178AA Expiration date: 30-NOV-2022) On 21-Apr-2022, (Latency: same day) the patient was administered two doses of acthib with no reported adverse event (extra dose administered) Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-